Crossmark

Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry

Published Online: 2022-06-20

Published Print: 2022-10

Authors

Kasvis, Popi

Canac-Marquis, Michelle

Aprikian, Saro

Vigano, MariaLuisa

Vigano, Antonio
License Information

Text and Data Mining valid from 2022-06-20

Version of Record valid from 2022-06-20
More Information

Article History

Received: 13 July 2021

Accepted: 30 May 2022

First Online: 20 June 2022

Declarations

:

: Ethical approval for the QCR was granted by the McGill University Health Center Research Ethics Board.

: All patients provided informed consent prior to participating in the QCR.

: All patients provided informed consent to the eventual publication of results from the data collected, prior to participating in the QCR.

: S. A. holds stock options in a licensed medical cannabis producer (Tilray); A. V. sat on the medical advisory boards of licensed producers of medical cannabis in Canada (Spectrum Therapeutics, Tilray, Syqe, and EmpowerPharm) and is the former research director for Santé Cannabis, Montreal, Canada. All other authors declare no competing interests.

Document is current